ロード中...

Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives

Idiopathic pulmonary fibrosis is a progressive and fatal fibrotic lung disease which has seen new opportunity for drug treatment in the last several years with the approval of nintedanib and pirfenidone, two antifibrotic agents aimed at slowing decline in lung function as defined by FVC on pulmonary...

詳細記述

保存先:
書誌詳細
出版年:Ther Clin Risk Manag
主要な著者: Moua, Teng, Ryu, Jay H
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6322512/
https://ncbi.nlm.nih.gov/pubmed/30655671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S160248
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!